United States · 
Who invested in Kinnate Biopharma?
Kinnate Biopharma's investors include OrbiMed, Foresite Capital, Nextech Invest, Vida Ventures and Eshelman Ventures.
United States · Series B startup
Who invested in Kinnate Biopharma
Funding summaryUpdated 26 Oct 2026
$75Mraised across 1 round since 2019, from 1 source
- Latest round
- Series B, $75MDec 2019
- Investors
- 5
The rounds
- Dec 2019Series B$75M
Reported by FinSMEsSEC filing: $74M sold, first sale Dec 2019
Founders and team
From the SEC filings it signed: 3 on the team.
- Mark W. MeltzExecutive Officeri
- Nima W. FarzanExecutive Officer, Directori
- Stephen W. KaldorDirector, Promoteri
On the board, as filediCarl W. GordonDean W. MitchellJim W. TananbaumKeith W. FlahertyLaurie W. Smaldone AlsupMichael W. Rome
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about Kinnate Biopharma
How much has Kinnate Biopharma raised?
Kinnate Biopharma has raised $75M across 1 round since 2019.
When did Kinnate Biopharma last raise?
Kinnate Biopharma's most recent round was a Series B of $75M in Dec 2019.
What was Kinnate Biopharma's biggest round?
Its most recent round, $75M in Dec 2019, is also its largest on record.
Who backed Kinnate Biopharma first?
Kinnate Biopharma's first round on record, in Dec 2019, was backed by OrbiMed, Foresite Capital and Nextech Invest and 2 others.
What stage is Kinnate Biopharma at?
Kinnate Biopharma's latest named round is a Series B, in Dec 2019.
Where is Kinnate Biopharma based?
Kinnate Biopharma is based in the United States.
Companies like Kinnate Biopharma
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.